276 related articles for article (PubMed ID: 27335842)
1. Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.
Macias RI
ISRN Hepatol; 2014; 2014():828074. PubMed ID: 27335842
[TBL] [Abstract][Full Text] [Related]
2. Cancer review: Cholangiocarcinoma.
Ghouri YA; Mian I; Blechacz B
J Carcinog; 2015; 14():1. PubMed ID: 25788866
[TBL] [Abstract][Full Text] [Related]
3. Future directions in the treatment of cholangiocarcinoma.
Zhu AX
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
[TBL] [Abstract][Full Text] [Related]
4. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.
Nakeeb A; Pitt HA; Sohn TA; Coleman J; Abrams RA; Piantadosi S; Hruban RH; Lillemoe KD; Yeo CJ; Cameron JL
Ann Surg; 1996 Oct; 224(4):463-73; discussion 473-5. PubMed ID: 8857851
[TBL] [Abstract][Full Text] [Related]
5. Latest evidence on immunotherapy for cholangiocarcinoma.
Guo X; Shen W
Oncol Lett; 2020 Dec; 20(6):381. PubMed ID: 33154779
[TBL] [Abstract][Full Text] [Related]
6. Immunobiology of cholangiocarcinoma.
Loeuillard E; Conboy CB; Gores GJ; Rizvi S
JHEP Rep; 2019 Oct; 1(4):297-311. PubMed ID: 32039381
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinoma in the Era of Immunotherapy.
Manthopoulou E; Ramai D; Dhar J; Samanta J; Ioannou A; Lusina E; Sacco R; Facciorusso A
Vaccines (Basel); 2023 Jun; 11(6):. PubMed ID: 37376451
[TBL] [Abstract][Full Text] [Related]
8. Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies.
Schweitzer N; Vogel A
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):345-53. PubMed ID: 25966433
[TBL] [Abstract][Full Text] [Related]
9. Moving forward in the treatment of cholangiocarcinoma.
Manzia TM; Parente A; Lenci I; Sensi B; Milana M; Gazia C; Signorello A; Angelico R; Grassi G; Tisone G; Baiocchi L
World J Gastrointest Oncol; 2021 Dec; 13(12):1939-1955. PubMed ID: 35070034
[TBL] [Abstract][Full Text] [Related]
10. A review of the clinical diagnosis and therapy of cholangiocarcinoma.
Yao D; Kunam VK; Li X
J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497
[TBL] [Abstract][Full Text] [Related]
11. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma?
Slattery JM; Sahani DV
Oncologist; 2006 Sep; 11(8):913-22. PubMed ID: 16951395
[TBL] [Abstract][Full Text] [Related]
12. Improved survival in resected biliary malignancies.
Nakeeb A; Tran KQ; Black MJ; Erickson BA; Ritch PS; Quebbeman EJ; Wilson SD; Demeure MJ; Rilling WS; Dua KS; Pitt HA
Surgery; 2002 Oct; 132(4):555-63; discission 563-4. PubMed ID: 12407338
[TBL] [Abstract][Full Text] [Related]
13. New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin.
Bragazzi MC; Ridola L; Safarikia S; Matteo SD; Costantini D; Nevi L; Cardinale V
Ann Gastroenterol; 2018; 31(1):42-55. PubMed ID: 29333066
[TBL] [Abstract][Full Text] [Related]
14. Cholangiocarcinoma Prognosis Varies over Time Depending on Tumor Site and Pathology.
Kaneko R; Sato Y; Kobayashi Y
J Gastrointestin Liver Dis; 2018 Mar; 27(1):59-66. PubMed ID: 29557416
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation, diagnosis and staging of cholangiocarcinoma.
Forner A; Vidili G; Rengo M; Bujanda L; Ponz-Sarvisé M; Lamarca A
Liver Int; 2019 May; 39 Suppl 1():98-107. PubMed ID: 30831002
[TBL] [Abstract][Full Text] [Related]
16. Imaging bile duct tumors: staging.
Ayuso JR; Pagés M; Darnell A
Abdom Imaging; 2013 Oct; 38(5):1071-81. PubMed ID: 23793410
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma.
Khan AS; Dageforde LA
Surg Clin North Am; 2019 Apr; 99(2):315-335. PubMed ID: 30846037
[TBL] [Abstract][Full Text] [Related]
18. Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.
Golan T; Raitses-Gurevich M; Kelley RK; Bocobo AG; Borgida A; Shroff RT; Holter S; Gallinger S; Ahn DH; Aderka D; Apurva J; Bekaii-Saab T; Friedman E; Javle M
Oncologist; 2017 Jul; 22(7):804-810. PubMed ID: 28487467
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience.
Khuntikeo N; Pugkhem A; Titapun A; Bhudhisawasdi V
J Hepatobiliary Pancreat Sci; 2014 Aug; 21(8):521-4. PubMed ID: 24464976
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodies.
Kriegsmann M; Roessler S; Kriegsmann K; Renner M; Longuespée R; Albrecht T; Loeffler M; Singer S; Mehrabi A; Vogel MN; Pathil A; Köhler B; Springfeld C; Rupp C; Weiss KH; Goeppert B
BMC Cancer; 2019 Jan; 19(1):72. PubMed ID: 30646854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
